Abstract
Worldwide, cervical cancer incidence is 75% higher than the projected ideal set by the World Health Organization. Despite an effective screen for in situ stage cancer, many women do not adhere to regular screening schedules. These delays raise mortality rates, since curative therapies are available only for the early stages of disease. Seeking to improve cancer control among women, investigators have developed a variety of methods to improve adherence rates. This article presents these methods as well as the cost-effectiveness of each when evaluative data are available. The article suggests that nurses may draw upon current knowledge to design and test the effectiveness of cancer control models in the catchment areas served by their institutions and agencies.